Skip to main content
. 2013 Jul 31;28(8):1134–1138. doi: 10.3346/jkms.2013.28.8.1134

Table 2.

Radiographic progression between patients who took tofacitinib and those who took conventional DMARDs. SENS score change during the interval was compared between the groups

graphic file with name jkms-28-1134-i002.jpg

*Mann-Whitney test. DMARD, disease modifying anti-rheumatic drug; SD, standard deviation.